News

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...
SIX artificial intelligence (AI) models recently went head-to-head with seasoned equity analysts to produce Swot (strengths, ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to DATROWAY® (datopotamab deruxtecan-dlnk) for ...
A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...
MerckMRK has built a substantial portfolio of new products and pipeline candidates in areas like oncology, vaccines, ...
Lea first spotted a small lump on her right breast but was reassured her 'lumpy boobs' were just due to hormones ...
Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...
A Brit woman was given a shocking diagnosis of stage 4 breast cancer after she said her tumour was repeatedly dismissed as ...
A woman was diagnosed with incurable stage 4 breast cancer after her tumour was dismissed as 'lumpy boobs' for two years. Lea ...
The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...
Cambridge-based AstraZeneca looks like it has set another drug on its way to blockbuster status - Datroway for the treatment ...